![dialysis machine at patient hospital bedside](/themes/custom/pharmaphorum_theme/library/img/empty.jpg)
Baxter slims down again, selling kidney division to Carlyle
Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations a